Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ibio Inc (IBIO)
NYSE MKT:IBIO
Holding IBIO?
Track your performance easily
IBIO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.02 - $6.12
Previous Close$2.56
Volume99.58K
Average Volume (3M)128.46K
Market Cap
$23.42M
Enterprise Value$16.82M
Total Cash (Recent Filing)$11.04M
Total Debt (Recent Filing)$4.43M
Price to Earnings (P/E)―
Beta2.30
Next Earnings
May 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.64
Shares Outstanding9,149,470
10 Day Avg. Volume95,830
30 Day Avg. Volume128,461
Standard Deviation1.13
R-Squared0.02
Alpha0.17
Financial Highlights & Ratios
Price to Book (P/B)1.13
Price to Sales (P/S)116.59
Price to Cash Flow (P/CF)-1.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue336.31
Enterprise Value/Gross Profit-3.42
Enterprise Value/Ebitda-1.13
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ibio News
PremiumCompany Announcements
iBio Unveils AI-Driven Antibody Discovery Strategy
PremiumCompany Announcements
iBio Updates CEO Employment Terms and Compensation Package
Ownership Overview
12.42%
Insiders
1.01% Mutual Funds
25.29% Other Institutional Investors
60.84% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
IBIO FAQ
What was Ibio Inc’s price range in the past 12 months?
Ibio Inc lowest stock price was $1.02 and its highest was $6.12 in the past 12 months.
What is Ibio Inc’s market cap?
Currently, no data Available
When is Ibio Inc’s upcoming earnings report date?
Ibio Inc’s upcoming earnings report date is May 19, 2025 which is in 174 days.
How were Ibio Inc’s earnings last quarter?
Ibio Inc released its earnings results on Sep 20, 2024. The company reported -$0.38 earnings per share for the quarter, beating the consensus estimate of -$0.47 by $0.09.
Is Ibio Inc overvalued?
According to Wall Street analysts Ibio Inc’s price is currently Overvalued.
Does Ibio Inc pay dividends?
Ibio Inc does not currently pay dividends.
What is Ibio Inc’s EPS estimate?
Ibio Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ibio Inc have?
Ibio Inc has 9,149,470 shares outstanding.
What happened to Ibio Inc’s price movement after its last earnings report?
Ibio Inc reported an EPS of -$0.38 in its last earnings report, beating expectations of -$0.47. Following the earnings report the stock price went down -6.091%.
Which hedge fund is a major shareholder of Ibio Inc?
Currently, no hedge funds are holding shares in IBIO
---
Ibio Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
IBIO Sentiment 100%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.6%
Last 30 Days ▼ 5.2%
Last 30 Days ▼ 5.2%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-54.24%
12-Months-Change
Fundamentals
Return on Equity
-92.74%
Trailing 12-Months
Asset Growth
-34.93%
Trailing 12-Months
Company Description
Ibio Inc
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY.
---
IBIO Stock 12 Month Forecast
Average Price Target
―Technical Analysis
ADMA Biologics
―
Aethlon Medical
―
XTL Biopharmaceuticals Ltd. Sponsored ADR
―
Cyclacel Pharmaceuticals
―
Best Analysts Covering IBIO
1 Year
1 Year Success Rate
2/2 ratings generated profit
1 Year Average Return
+9.95%
reiterated a buy rating 6 months ago
Copying Keay Nakae's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +9.95% per trade.
---